Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "United States Private Equity Market, By Region, Competition, Forecast and Opportunities, 2020-2030F" report has been added to ResearchAndMarkets.com's...
-
FundCanna, the leader in cannabis financing, announces the launch of B2B Buy Now, Pay Later solution for the Cannabis industry, ReadyPaid
-
The Phase 3 clinical trial will evaluate gedatolisib plus a CDK4/6 inhibitor and fulvestrant as first-line treatment for patients with HR+/HER2- advanced breast cancer who are endocrine therapy...
-
New York, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Nammu21, the leading digital solution for complex private credit instruments and Fiùtur, the trust and governance infrastructure for the transition...
-
New York, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Nammu21, the leading digital solution for complex private credit instruments and Fiùtur, the trust and governance infrastructure for the transition...
-
Arlington, VA, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Summit Ridge Energy, the nation's largest commercial solar company, has announced a $275 million expansion of its existing partnership with MUFG, a...
-
VANCOUVER, British Columbia, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi Health” or the “Company”), a Canadian drug research and formulation...
-
SAN DIEGO, Sept. 27, 2023 (GLOBE NEWSWIRE) -- FundCanna, the leading provider of capital to small to medium-sized businesses throughout the cannabis sector, announces today a partnership with...
-
VANCOUVER, British Columbia, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi Health” or the “Company”), a Canadian drug research and formulation...
-
VANCOUVER, British Columbia, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian drug research and formulation company licensed by Health Canada...